Omid Moradi

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 8

Top Topics

Randomized Controlled Trial

Juvenile Idiopathic Arthritis

Respiratory Syndrome Coronavirus

Extracorporeal Membrane Oxygenation

Top Venues

Iranian journal of pharmaceutical research : IJPR

Journal of medical virology

International journal of clinical practice

Immunity, inflammation and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Sedigheh Rafiei Tabatabaei, Omid Moradi, Abdollah Karimi, Shahnaz Armin, Alireza Fahimzad, Roxana Mansour Ghanaie, Mahnaz Jamee, Azam Mousavizadeh, Hossein Amini, Bahador Mirrahimi
A Single-Centered Cohort Study on Favipiravir Safety and Efficacy in Pediatric Patients with COVID-19. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Sedigheh Rafiei Tabatabaei, Omid Moradi, Abdollah Karimi, Shahnaz Armin, Alireza Fahimzad, Roxana Mansour Ghanaie, Mahnaz Jamee, Azam Mousavizadeh, Hossein Amini, Bahador Mirrahimi
A Single-Centered Cohort Study on Favipiravir Safety and Efficacy in Pediatric Patients with COVID-19. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Ilad Alavi Darazam, Kimia Forouhar, Omid Moradi, Ali Saffaei, Mahtabalsadat Mirjalili, Zahra Sahraei
Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Ilad Alavi Darazam, Kimia Forouhar, Omid Moradi, Ali Saffaei, Mahtabalsadat Mirjalili, Zahra Sahraei
Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Mohammad Haji Aghajani, Omid Moradi, Hamed Azhdari Tehrani, Hossein Amini, Elham Pourheidar, Firouze Hatami, Mohammad Mahdi Rabiei, Mohammad Sistanizd
Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID-19; a retrospective cohort study. International journal of clinical practice 75 (9) (2021)
Amir Behnam Kharazmi, Omid Moradi, Mehrdad Haghighi, Mehran Kouchek, Alireza Manafi-Rasi, Masoomeh Raoufi, Simin Dokht Shoaei, Fahimeh Hadavand, Mahmood Nabavi, Mir Mohammad Miri, Sara Salarian, Seyedpouzhia Shojaei, Shayesteh Khalili, Mohammad Sistanizd, Setayesh Sadeghi, Amirhossein Karagah, Saemeh Asgari, Morteza Jaffaraghaei, Shahram Araghi
A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19. Immunity, inflammation and disease (2021)
Mohammad Haji Aghajani, Omid Moradi, Hossein Amini, Hamed Azhdari Tehrani, Elham Pourheidar, Mohammad M Rabiei, Mohammad Sistanizad
Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19. Journal of medical virology 93 (9) (2021)
Minoosh Shabani Barzegar, Shervin Shokouhi, Omid Moradi, Ali Saffaei, Zahra Sahraei
Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion. Journal of medical virology 93 (1) (2020)